products aor inflammation-relief

Inflammation Relief

By : AOR - Advanced Orthomolecular Research


• Inflammation
• Infections
• Joint Pain and Stiffness
• Cadiovascular disease
• Cellular growth & differentiation
• Autoimmune diseases
• Inflammatory Bowel disease
• Infection


Supplement Facts
Serving Size:1 Capsule

Longvida® Optimized Curcumin* (from Curcuma longa root 25:1)...80 mg
Boswellia serrata ( 40% boswellic acids)...166.5 mg
Ashwagandha (10:1 extract)...33.3 mg

* LONGVIDA® is a registered trademark of/ Verdure Sciences Inc. International patent pending. Non-medicinal ingredients: oleanolic acid, potato starch, medium chain triglycerides, ascorbyl palmitate, microcrystalline cellulose, soy lecithin, stearic acid, maltodextrin, dextrin, silicon dioxide, polysorbate 20. Capsule: hypromellose, chlorophyll

AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, nuts, dairy, eggs, fish, shellfish, or any animal byproduct.


Inflammation Relief is formulated to maximize the bioavailability of standardized Boswellia serrata extract, Curcuma longa from Longvida®* and ashwagandha, which are botanicals used in traditional Ayurvedic medicine. Inflammation Relief is used in herbal medicine as an anti-inflammatory to help relieve joint pain.


60 Liquid Caps
280 mg


Take 1 capsule one to three times a day with food, or as directed by a qualified health care practitioner.

Potential side effects/Safety

Cautions: Consult a health care practitioner before use if you are taking antiplatelet medication or blood thinners, have gallstones, bile duct obstruction, stomach ulcers, have excess stomach acid, or if symptoms persist or worsen. Some people may experience mild gastrointestinal effects such as diarrhea, abdominal pain/cramps and nausea. Discontinue use if hypersensitivity (e.g. allergy) occurs. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.

Pregnancy/Nursing: Consult a health care practitioner before use


"Show references"

"Hide references"

Aggarwal BB, et al. Curcumin as Curecumin: From kitchen to clinic. Biochemical Pharmacology Volume 75, Issue 4, 15 February 2008, Pages 787-809. 4. Satoskar RR, et al. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):651-4.

Aggarwal BB, et al. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NFkappaB) activation and NF-kappaB-regulated gene expression. Mol Cancer Ther. 2006 Jun;5(6):1434-45.

Bowellia Serrata. Monograph. Altern Med Rev. 2008 Jun;13(2):165-7.
Deodhar S.D. , Sethi R. andSrimal, R.C.Preliminary study on antirheumatic activity of curcumin (diferuloyl methane), Indian J Med Res 71 (1980), pp. 632-634.

Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine 2003 Jan; 10(1): 3-7.

Klement JF, et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol. 1996 May;16(5):2341-9.

Kulkarni RR, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol. 1991 May-Jun;33(1-2):91-5.

Suh SJ, et al. Triterpenoid saponin, oleanolic acid 3-O-beta-d-glucopyranosyl(1–>3)-alpha-l-rhamnopyranosyl(1–>2)-alpha-l-arabinopyranoside (OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-kappaB in raw 264.7 cells. Arch Biochem Biophys. 2007 Nov 15 ;467(2):227-33.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. © 2015 NDAssist Inc. and/or its affiliates. All rights reserved.